Complement, age-related macular degeneration and a vision of the future.

Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS
Arch Ophthalmol. 2010 128 (3): 349-58

PMID: 20212207 · PMCID: PMC4405117 · DOI:10.1001/archophthalmol.2010.18

Age-related macular degeneration (AMD) is one of the most well-characterized late-onset, complex trait diseases. Remarkable advances in our understanding of the genetic and biological foundations of this disease were derived from a recent convergence of scientific and clinical data. Importantly, the more recent identification of AMD-associated variations in a number of complement pathway genes has provided strong support for earlier, paradigm-shifting studies that suggested that aberrant function of the complement system plays a key role in disease etiology. Collectively, this wealth of information has provided an impetus for the development of powerful tools to accurately diagnose disease risk and progression and complement-based therapeutics that will ultimately delay or prevent AMD. Indeed, we are poised to witness a new era of a personalized approach toward the assessment, management, and treatment of this debilitating, chronic disease.

MeSH Terms (4)

Complement System Proteins Genetic Techniques Humans Macular Degeneration

Connections (1)

This publication is referenced by other Labnodes entities: